ROSEVILLE, Minn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and nine months ended December 28, 2025, its third quarter of fiscal 2026. Third Quarter Fiscal Year 2026 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure.Revenue growth of 8% over the same period of the prior year, including Water Treatmen ...

ROSEVILLE, Minn., Jan. 28, 2026 (GLOBE NEWSWIRE) -- At its recent board meeting, the Board of Directors of Hawkins, Inc. (Nasdaq: HWKN) declared a quarterly cash dividend of $0.19 per share, payable February 27, 2026, to shareholders of record at the close of business on February 13, 2026. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distribut ...

Core Insights - Rivermont Capital Management reduced its stake in Sensient Technologies Corporation by 205,939 shares, resulting in a value decrease of $20.65 million, bringing the total position value to $7.19 million at quarter-end [1][2] Company Overview - Sensient Technologies Corporation reported a total revenue of $1.60 billion and a net income of $139.11 million for the trailing twelve months (TTM) [4] - The company has a dividend yield of 1.7% and its shares were priced at $96.11, reflecting a 32% increase over the past year, significantly outperforming the S&P 500, which rose by 15% in the same period [3][4] Business Segments - Sensient operates through three main segments: Flavors & Extracts Group, Color Group, and Asia Pacific Group, serving a diverse global customer base across food, beverage, personal care, and household products industries [7] Recent Performance - The company experienced a strong third quarter, with revenue increasing by 5%, operating income rising over 14%, and earnings per share reaching $0.87, primarily driven by margin expansion in the Color segment [8] - Management has raised expectations for local-currency adjusted EBITDA growth, indicating confidence in future performance [8] Market Position - Sensient maintains reliable cash flow, pricing power in natural colors, and manageable leverage, suggesting a solid fundamental position despite the recent stake reduction by Rivermont Capital Management [10]

Core Insights - Balchem, a leader in specialty ingredients for food, pharmaceutical, and animal health markets, reported significant insider selling activity by Director David B Fischer [1][2]. Transaction Summary - On December 3, 2025, David B Fischer sold 8,000 common shares for a total of $1,231,748.20, following the exercise of 6,000 fully vested options [2][3]. - Post-transaction, Fischer's direct share count decreased by 50%, from 15,989 to 7,989 shares, representing approximately 0.025% of shares outstanding [6]. - The weighted average sale price was $153.97, closely aligning with the market closing price of $156.2 on December 12, 2025 [6]. Company Overview - Balchem reported a total revenue of $1.01 billion and a net income of $149.2 million for the trailing twelve months (TTM) [5]. - The company has a dividend yield of 0.61% and experienced a 1-year price change of -12.4% [5]. Business Operations - Balchem specializes in providing ingredients for human nutrition, animal nutrition, and specialty industrial applications, including microencapsulated nutrients and sterilization agents [7]. - The company serves various sectors, including food and beverage manufacturers, pharmaceutical companies, and agricultural businesses, both domestically and internationally [7]. Strategic Initiatives - Balchem is investing in growth by building a new facility for producing microencapsulated food ingredients and nutraceuticals, which will more than double its current capacity [11]. - This investment is a response to increasing demand, indicating potential for continued business growth [12]. Recent Developments - Following the insider selling, Balchem announced a 10.3% dividend increase, marking the 17th consecutive annual dividend increase [10]. - The company also reported record quarterly sales, which increased by 11.5% year over year [11].

Core Insights - Balchem Corporation will present at Baird's 55th Annual Global Industrial Conference on November 12, 2025, with key executives participating [1] Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets, offering solutions across various industries [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products segment offers specialty-packaged chemicals for healthcare and other industries, including chelated minerals for the agricultural market [2]

2 • During the course of this presentation, management may make forward-looking statements regarding financial performance and future events. • These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "forecast," "outlook," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," or the negative thereof or variations thereon or similar expressions generall ...

Core Insights - Hawkins, Inc. has been recognized as one of America's Greatest Companies 2025 by Newsweek, highlighting its commitment to excellence, innovation, and service [1] - The company has received multiple awards this year, reflecting its strong culture and dedication to its employees and communities [1][2] Company Overview - Hawkins, Inc. was founded in 1938 and specializes in water treatment and specialty ingredients, serving customers in Water Treatment, Food & Health Sciences, and Industrial Solutions [3] - The company is headquartered in Roseville, Minnesota, operates 64 facilities across 28 states, and generated $974 million in revenue for fiscal 2025 with approximately 1,100 employees [3] Awards and Recognition - The company is Great Place to Work® Certified, indicating its commitment to an inclusive and rewarding workplace [4] - It has been recognized as one of Newsweek® America's Most Responsible Companies, showcasing its leadership in sustainability and ethical business practices [4] - Hawkins was listed among the Minneapolis/St.Paul Business Journal® Fastest Growing Public Companies in Minnesota, reflecting strong year-over-year growth [4] - The company also made it to Fortune's Top Workplaces in Manufacturing and Production 2025, emphasizing its positive work environment [4]

Financial Performance - Q2 2025 - Sales increased by 9.1% to $255.5 million in Q2 2025, compared to $234.1 million in Q2 2024[54] - Adjusted EBITDA increased by 11.2% to $69.2 million in Q2 2025[56] - Adjusted Net Earnings increased by 16.8% to $41.6 million in Q2 2025, compared to $35.6 million in Q2 2024[58] - Adjusted EPS increased by 16.5% to $1.27 per share in Q2 2025, compared to $1.09 per share in Q2 2024[59, 60] Financial Performance - YTD 2025 - Sales increased by 6.8% to $506.0 million YTD 2025, compared to $473.7 million YTD 2024[63] - Adjusted EBITDA increased by 10.1% to $135.5 million YTD 2025[65] - Adjusted Net Earnings increased by 18.0% to $81.6 million YTD 2025, compared to $69.2 million YTD 2024[67] - Adjusted EPS increased by 17.5% to $2.49 per share YTD 2025, compared to $2.12 per share YTD 2024[69] Overall Company Financials - 2024 Sales were $954 million[9] - 2024 Adjusted EBITDA was $250 million with a margin of 26.3%[11]

Core Insights - Hawkins, Inc. reported record revenue of $293 million for the first quarter of fiscal 2026, marking a 15% increase year-over-year, with all three reporting segments contributing to this growth [3][6][7] - The Water Treatment segment experienced significant growth, with a 28% increase in sales, driven by both acquired businesses and improved pricing [3][8] - The company successfully completed the acquisition of WaterSurplus, enhancing its capabilities in water treatment and positioning for future growth [3][6][19] Financial Performance - Net income for the first quarter was $29.2 million, or $1.40 per diluted share, compared to $28.9 million, or $1.38 per diluted share in the prior year [5][6] - Adjusted EBITDA increased by 13% to $57.6 million, with trailing twelve-month adjusted EBITDA exceeding $170 million [6][17] - Gross profit rose by 12% to $72.4 million, maintaining a gross margin of 25% [6][11] Segment Performance - Water Treatment segment sales increased by $32.4 million, or 28%, to $149.6 million [8][32] - Food & Health Sciences segment sales grew by $4.1 million, or 5%, to $89.2 million, with agricultural products driving the increase despite competitive pricing pressures [9][32] - Industrial Solutions segment sales saw a modest increase of $0.9 million, or 2%, to $54.5 million, primarily due to higher sales volumes [10][32] Expenses and Balance Sheet - Selling, general and administrative expenses rose by 24% to $31 million, largely due to costs associated with the WaterSurplus acquisition [15][32] - The company's leverage ratio at the end of the first quarter was 1.6x, reflecting a strong balance sheet despite increased debt from the acquisition [3][19] - Working capital increased by $22 million compared to the end of fiscal 2025, driven by higher inventories and receivables [19][27]

Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [2] Upcoming Events - Balchem Corporation will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025 [1] - Key executives attending the conference include Ted Harris (Chairman, CEO, and President), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) [1]